RxDoctor Payments Data

Aaron Starbuck, MD

Family Medicine · Orem, UTNPI 1336288034

Payments from drug & device makers

$3,644in general payments, 2019–2025

Across 225 payments — averaging $16.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$491
  • AbbVie$436
  • Lilly USA, LLC$430
  • Merck$301
  • Novo Nordisk$287
  • AstraZeneca$266
  • plus $1K from 27 others

What the payments were for

  • Food & beverage$3,644100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,644 in reported general payments places this provider in the 75th percentile of 928 family medicine providers in Utah.

See all family medicine providers in Utah

Medicare billing

Part B allowed, 2024
$56,999
Medicare patients
87
Services billed
936

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban45$38,423
OzempicSemaglutide22$22,886
TrulicityDulaglutide18$20,204
JardianceEmpagliflozin18$15,604
MyrbetriqMirabegron19$13,195
RybelsusSemaglutide12$11,689
Xigduo XrDapaglifloz Propaned/Metformin14$11,504
FarxigaDapagliflozin Propanediol11$6,520
Breo ElliptaFluticasone/Vilanterol13$4,075
Clonidine14$2,393
Atorvastatin Calcium133$1,479
Omeprazole64$1,408
Gabapentin69$1,398
Fluticasone Propionate42$1,235
Albuterol Sulfate HfaAlbuterol Sulfate48$1,175

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$153$38,42345 claims
Novo NordiskOzempic, Rybelsus$287$34,57634 claims
Lilly USA, LLCTrulicity$430$20,20418 claims
Boehringer IngelheimJardiance$491$15,60418 claims
Astellas Pharma US IncMyrbetriq$192$13,19519 claims
AstraZenecaFarxiga$266$6,52011 claims
GSKBreo Ellipta$141$4,07513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 928 family medicine providers in Utah.

Other family medicine in Orem

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →